Skip to main content

Table 2 Correlations between [18F]flortaucipir BPND and regional GM density in the total group, cognitively normal individuals and MCI/AD

From: Associations between quantitative [18F]flortaucipir tau PET and atrophy across the Alzheimer’s disease spectrum

 

Entorhinal cortex

Hippocampus

Medial temporal

Lateral temporal

Medial parietal

Lateral parietal

Occipital

Frontal

Global

Total group

 [18F]Flortaucipir BPND entorhinal cortex

− 0.422**#

− 0.505**#

− 0.491**#

− 0.424**#

− 0.362**#

− 0.358**#

− 0.392**#

− 0.335**#

− 0.377**#

 [18F]Flortaucipir BPND in ROI Braak III–IV

− 0.410**#

− 0.439**#

− 0.439**#

− 0.598**#

− 0.493**#

− 0.475**#

− 0.552**#

− 0.378**#

− 0.472**#

 [18F]Flortaucipir BPND in ROI Braak V–VI

− 0.344**#

− 0.393**#

− 0.385**#

− 0.592**#

− 0.548**#

− 0.546**#

− 0.627**#

− 0.405**#

− 0.499**#

Cognitively normal

 [18F]Flortaucipir BPND entorhinal cortex

0.004

− 0.090

− 0.080

− 0.087

− 0.116

− 0.027

− 0.129

− 0.198

− 0.114

 [18F]Flortaucipir BPND in ROI Braak III–IV

− 0.087

− 0.070

− 0.089

− 0.120

− 0.190

− 0.048

− 0.015

− 0.033

− 0.079

 [18F]Flortaucipir BPND in ROI Braak V–VI

− 0.057

− 0.053

− 0.068

− 0.137

− 0.229

− 0.122

− 0.064

− 0.130

− 0.099

MCI/AD

 [18F]Flortaucipir BPND entorhinal cortex

− 0.378**#

− 0.422**#

− 0.404**#

− 0.226*

− 0.116

− 0.132

− 0.114

− 0.210*

− 0.211*

 [18F]Flortaucipir BPND in ROI Braak III–IV

− 0.256*

− 0.209

− 0.224

− 0.555**#

− 0.350**#

− 0.348**#

− 0.432**#

− 0.299**#

− 0.393**#

 [18F]Flortaucipir BPND in ROI Braak V–VI

− 0.132

− 0.119

− 0.123

− 0.529**#

− 0.451**#

− 0.460**#

− 0.548**#

− 0.329**#

− 0.431**#

  1. *p < 0.05, **p < 0.01, #FDR corrected